Durvalumab (D) +/- Tremelimumab (T) Plus Platinum-Etoposide (Ep) In 1l Es-Sclc: Characterization Of Long-Term Clinical Benefit And Tumour Mutational Burden (Tmb) In CaspianJ. W. Goldman,M. C. Garassino,Y. Chen,N. Reinmuth,K. Hotta,A. Poltoratskiy,D. Trukhin,M. J. Hochmair,M. Ozguroglu,J. H. Ji,G. Statsenko,O. Voitko,N. V. Conev,I. Bondarenko,S. Spencer,M. Xie,S. Jones,A. Franks,Y. Shrestha,L. Paz-AresANNALS OF ONCOLOGY（2020）引用 21|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
